Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 27 points (-0.2%) at 16,879 as of Thursday, June 19, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,678 issues advancing vs. 1,278 declining with 191 unchanged. The Health Services industry currently is unchanged today versus the S&P 500, which is down 0.1%. Top gainers within the industry include Smith & Nephew ( SNN), up 1.1%, Stryker Corporation ( SYK), up 1.1%, Covidien ( COV), up 0.7% and Abbott Laboratories ( ABT), up 0.5%. On the negative front, top decliners within the industry include Waters ( WAT), down 1.3%, and Agilent Technologies ( A), down 0.6%. TheStreet would like to highlight 3 stocks pushing the industry higher today: 3. WellPoint ( WLP) is one of the companies pushing the Health Services industry higher today. As of noon trading, WellPoint is up $0.75 (0.7%) to $107.00 on light volume. Thus far, 355,465 shares of WellPoint exchanged hands as compared to its average daily volume of 2.4 million shares. The stock has ranged in price between $106.32-$107.09 after having opened the day at $106.49 as compared to the previous trading day's close of $106.25. WellPoint, Inc., a health benefits company, through its subsidiaries, provides a range of medical products in the United States. The company offers a spectrum of network-based managed care health benefit plans to large and small employer, individual, Medicaid, and senior markets. WellPoint has a market cap of $29.7 billion and is part of the health care sector. Shares are up 15.0% year-to-date as of the close of trading on Wednesday. Currently there are 7 analysts who rate WellPoint a buy, no analysts rate it a sell, and 11 rate it a hold. TheStreet Ratings rates WellPoint as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels and good cash flow from operations. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full WellPoint Ratings Report now. 3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.